Grants for Unrestricted - Health

The Women’s Fund, an endowment fund within the Community Foundation of Middle Tennessee, is dedicated to fund long-term solutions to transform the lives of women and girls in Middle Tennessee. Donor Name: Community Foundation Middle Tennessee State: Tennessee County: Selected Counties Type of Grant: Grant Deadline: (mm/dd/yyyy) 08/31/2024 Size of the Grant: $1000 to $10,000 Grant Duration: 1 Year Details: The Women’s Fund grants are classified as unrestricted operating support. Funds may be used at the discretion of the organization to cover any costs necessary to carry out its core mission and programs within one of The Women’s Fund focus areas. The Women’s Fund is prioritizing supporting organizations whose total operating budget is less than $3,000,000, however, those above that amount are still eligible to apply. Funding Goals Increase Economic self-sufficiency for women; Improve strategies for the prevention of violence against women and girls; Promotion of health, well-being, and talent of women and girls. Funding Information The Women’s Fund maximum grant award will be $20,000 for organizations 3 years or older. Organizations under 3 years old may request up to a maximum of $5,000. Grant Period December 1, 2024 – November 30, 2025. For more information, visit CFMT.

This grant provides funding to organizations working in the Eastern and Southern Caribbean to develop programs that help youth avoid gang involvement and related violence through community support, education, and rehabilitation initiatives.

United States Agency for International Development (USAID) Mozambique is planning the Ensuring Social Protection by Empowering and building Resiliency for Adolescents, Nuclear families, Children, and caregivers affected by HIV/AIDS (ESPERANA) Activity, focused on improving health outcomes of households vulnerable to and impacted by HIV in Manica, Tete and Sofala.

The City of Bellingham is seeking proposals for its Tourism Promotion Grants to increase economic activity in the City of Bellingham resulting from Tourists. Donor Name: City of Bellingham State: County: All Counties Type of Grant: Grant Deadline: (mm/dd/yyyy) 09/06/2024 Size of the Grant: $10,000 to $100,000 Grant Duration: Grant Duration Not Mentioned Details: This is an opportunity to apply for funds to provide seed money for your new event or marketing funds for ongoing events. Ideally, putting heads in beds (hotel stays). Funding is limited to activities which draw tourists to Bellingham. Types of Grant The Start-Up Grant- They offer a Start-up Grant for those events or activities that are three years young. This allows you to utilize funds for more than just marketing. You can put some funds toward eligible operating expenses which are limited to venue rentals (i.e. conference rooms), equipment rentals (i.e. cones, traffic signs, etc.), a portion of rent (must be proportionate to the event), and/or the purchase of goods/supplies with prior approval by the City. For example, payroll, travel, alcohol and equipment expenses are NOT allowed. Final decisions by the City on allowed operational expenses will be identified in the contract, and all expenses must be incurred and paid during the contractual period with appropriate back-up documentation available. The Standard Grant- This grant is for those events or activities who are over three years running. Eligible operational expenses are limited to venue rentals (i.e. conference rooms), equipment rentals (i.e. cones, traffic signs, etc.), a portion of rent (must be proportionate to the event), and/or the purchase of goods/supplies with prior approval by the City. For example, payroll, travel, alcohol and equipment expenses are NOT allowed. Final decisions by the City on allowed operational expenses will be identified in the contract, and all expenses must be incurred and paid during the contractual period with appropriate back-up documentation available.  Funding Information Start-up grants have a maximum of $5,000 funding.  The Standard grant does not have a limit however generally funding amount ranges between $2,500 – $25,000. Marketing Requirements RCW 67.28.080 defines a tourist as people travelling: For business or pleasure staying overnight in paid accommodations, To a place 50 miles or more one way from their place of residence or business or From another country or state outside of their place of residence or their business. For more information, visit City of Bellingham.

The FY24 LCRP Translational Research Award mechanism supports advanced translational research that will foster transformation of promising ideas in lung cancer into clinical applications. Translational research may be defined as an integration of basic science and clinical observations. Observations that drive a research idea may originate from a laboratory discovery, population-based studies, or a clinicians firsthand knowledge of patient care. The ultimate goal of translational research is to move a concept or observation forward into clinical application. However, Principal Investigators (PIs) should not view translational research as a one-way continuum from bench to bedside but can include a reciprocal flow of ideas and information between basic science and clinical science (bench to bedside and/or bedside to bench). Research applications only in the area of mesothelioma will not be accepted. This mechanism is intended to fund a broad range of translational studies with two different funding levels. The following are general examples, although not all-inclusive, of the type of research projects that would be appropriate to propose under the current program announcement:Funding Level 1: Advanced preclinical studies aimed at translating results from animal studies to applications with human samples/cohorts (The Translational Research Award is not intended to support initial mechanistic studies of a new target.) Late-stage preclinical work leading to/preparing for a clinical trial, e.g., Investigational New Drug (IND) application submission Correlative studies that are associated with an open/ongoing or completed clinical trial, e.g., projects that utilize biospecimens from clinical trials to improve clinical management of lung cancer and/or define new areas of research Projects that develop endpoints for clinical trialsFunding Level 2 Pilot clinical trials where limited clinical testing (e.g., small sample size) of a novel intervention is necessary to inform the next step in the continuum of translational researchPreliminary lung cancer relevant data to support the feasibility of the research hypotheses and research approaches are required.

The Patient-Centered Outcomes and Survivorship Award supports high-risk, high-reward research studies that span the spectrum of behavioral health science, survivorship, health outcomes and comparative effectiveness research, including quality of life, symptom and side effect management, resilience, co-morbid conditions, and examining the physical, psychological, social, and economic effects of lung cancer among patients and their families.The overall intent of the FY24 LCRP Patient-Centered Outcomes and Survivorship Award is to promote evidence-based and patient-centered approaches to improve health and lung cancer related outcomes and enhance the patient experience in defined populations. Research studies may include, but are not limited to:Studies to examine and improve quality of life, decision-making, and symptom and side effect management (e.g., toxicity of treatment, palliative/supportive care, psychological distress and anxiety).Studies to investigate the impact of prevention, diagnostics, treatment, or health care delivery approaches on health outcomes.Studies to assess the relationship(s) between behavioral, cognitive, and/or social functioning in relation to lung cancer detection, initiation, progression, treatment, and rehabilitation.Studies into the psychological health and well-being of those affected by lung cancer (e.g., patients, family members).Development and testing for efficacy of lifestyle interventions and symptom management approaches to minimize disease risk and maximize quality of life.Key aspects of this award mechanism are:Impact: The Patient-Centered Outcomes and Survivorship Award is intended to support research that demonstrates the potential to have a major impact on patient outcomes. Research should challenge paradigms with respect to impact on patient care and outcomes. Proposed projects may include translational or clinical research, including pilot clinical trials. Impactful research will accelerate the movement of promising ideas into clinical applications, generate knowledge to improve clinical guidelines, or significantly advance behavioral, cognitive, and/or social functioning related to the target population.Study Design: Applications should clearly articulate the chosen design of the study. Basic studies should demonstrate research strategy, feasibility, and how the study relates to the human experience with lung cancer. Studies entailing retrospective or prospective recruitment should define the type of architecture of the study (e.g., descriptive, correlational, field experimental, meta-analyses). Study populations should be defined. The rationale should support the chosen study design with statistical evaluation to back the design. Questionnaires should be described in sufficient detail to justify interpretation of potential results.Preliminary Data: The Patient-Centered Outcomes and Survivorship Award requires preliminary data for all studies that propose the active (prospective) recruitment of human subjects. Studies not proposing active recruitment of human subjects are not required to present preliminary data but should be supported by sound reasoning and relevant literature.Patient Advocate Participation: Applications to the Patient-Centered Outcomes and Survivorship Award funding opportunity are encouraged to include a patient advocate. As part of the research team, the patient advocate would assist in the development of the research question, project design, oversight, recruitment, and evaluation, as well as other significant aspects of the proposed project. The patient advocate will be a person with a history of lung cancer diagnosis. As a lay representative, the patient advocate should be active in a cancer advocacy organization. Interactions with other team members should be well integrated and ongoing, not limited to attending seminars and semi-annual meetings. The role of the patient advocate should be focused on providing objective input on the research and its potential impact for individuals with or at risk for lung cancer.

Subject: Jordan RFI/SSN: Prevent, Detect, Respond - Primary Health Care (PDR-PHC) ActivityThe United States Agency for International Development in Jordan (USAID/Jordan) Mission isgathering information for a potential Global Health Security (GHS) activity. The Activity willinclude a package of interventions to strengthen biosecurity and safety, address antimicrobialresistance (AMR), and prevent and respond to emerging threats through building One Healthcapacities that incorporate linkages between human, animal, and environmental health.Through focusing its interventions at the primary healthcare level, the activity will strengthenhealth provider practices, health system preparedness, multi-sectoral coordination, andsurveillance capabilities to 1) prevent avoidable disease outbreaks, 2) detect threats early, 3)respond rapidly and effectively when outbreaks occur.This RFI/SSN seeks responses to the below inquiries as well as information on the availability,interest, and diverse capacities of GHS-focused entities to carry out such tasks and theirability to collaborate with local entities.This RFI/SSN is issued solely for information and planning purposes. It is NOT a Request forProposal (RFP), nor Notice of Funding Opportunity (NOFO), and in no way obligates the U.S.Government to issue an RFP/NOFO and/or award a contract/grant or pay for any informationsubmitted as a result of this request. If a solicitation is issued, all necessary information willbe supplied at the time it is posted at grants.gov or sam.gov.

The Ryan White HIV/AIDS Program Part A HIV Emergency Relief Grant Program is a funding opportunity aimed at providing financial assistance to metropolitan areas severely affected by HIV, with the goal of enhancing access to comprehensive, high-quality care for people with HIV and improving their health outcomes.

The Superior Health Foundation is currently accepting grant applications for its proactive grant-giving initiatives for 2023-2024. Donor Name: Superior Health Foundation (SHF) State: County: All Counties Type of Grant: Grant Deadline: (mm/dd/yyyy) 08/04/2024 Size of the Grant: More than $1 million Grant Duration: Grant Duration Not Mentioned Details: The Request For Proposals (RFP) to address pediatric mental health issues in the Upper Peninsula. The Superior Health Foundation — along with its funding partners, the Michigan Health Endowment Fund and the Blue Cross Blue Shield of Michigan Foundation — will award more than $1.3 million in grant funding to address Pediatric Mental Health. The Superior Health Foundation Grants Committee places a heavy emphasis on collaborative projects that have collective impact. For more information, visit Superior Health Foundation.

The Health and Human Services Commission (HHSC) seeks qualified Applicants to implement a Nutrition Incentive Program (NIP) Project. The purpose of the NIP Project is to increase the purchase of fruits and vegetables by low-income households participating in the United States Department of Agriculture Supplemental Nutritional Assistance Program (SNAP). Services must be provided in accordance with the specifications contained in this Request for Application (RFA). Applicants should reference Section II, Scope of Grant Project, for further detailed information regarding the purpose, background, eligible population, eligible activities, and requirements.

Dear Prospective Applicants:The United States Agency for International Development Mission in Burundi (USAID Burundi) is seeking applications from qualified entities to implement a five-year Activity that focuses on Reproductive, Maternal, Newborn, and Child Health, Immunization, and Malaria (RMNCI+M) in Burundi, titled Kira Ukuze, as further described in Section A of this Notice of Funding Opportunity (NOFO). Eligibility for this award is not restricted.Eligible parties interested in submitting an application are encouraged to read this NOFO thoroughly to understand the type of program sought, application submission requirements, and selection process. Applications pursuant to this NOFO will be reviewed utilizing the following two-step process:Phase I: Technical ApplicationApplicants will submit a technical application that will be reviewed for responsiveness to the objectives of this NOFO and then evaluated according to the specific criteria provided in Section E. Eligible parties interested in submitting a technical application are encouraged to thoroughly read this NOFO to understand the type of activity sought, application submission requirements, and selection process. Selected applicants will advance to the Phase II of the selection process to submit a revised technical and cost application.Phase II: Revised Technical Application and Cost ApplicationApplicant(s) advancing to Phase II will receive a list of identified weaknesses, questions, and requests for clarifications resulting from the review of the technical applications. Responses to USAID Burundi feedback must be incorporated into the revised technical application. Subject to the availability of funds, USAID Burundi intends to make a single award to the applicant who best meets the objectives of this funding opportunity based on the merit review criteria described in Section E of this NOFO, subject to a risk assessment in accordance with ADS 303.3.9. While an award is anticipated as a result of this NOFO, USAID Burundi reserves the right to fund any or none of the initial technical applications submitted.

Dear Prospective Applicants: The United States Agency for International Development (USAID) is seeking applications for a Cooperative Agreement from qualified entities to implement the above-mentioned Program outlined in the subject NOFO. Eligibility for this award is not restricted. USAID intends to make a single award to the applicant(s) who best meets the objectives of this funding opportunity based on the merit review criteria described in this NOFO subject to a risk assessment. Eligible entities interested in submitting an application are encouraged to read this NOFO thoroughly to understand the type of activity sought, application submission requirements, and selection process. Subject to funding availability, USAID intends to provide up to $13,000,000.00 in total USAID funding to the USAID The Gambia Malaria Elimination Activity (GMEA or activity). To be eligible for award, the applicant must provide all information as required in this NOFO and meet eligibility standards in Section C of this NOFO. This funding opportunity is posted on www.grants.gov, and may be amended. It is the responsibility of the applicant to regularly check the website to ensure they have the latest information pertaining to this notice of funding opportunity and to ensure that the NOFO has been received from the internet in its entirety. USAID bears no responsibility for data errors resulting from transmission or conversion process. If you have difficulty registering on www.grants.gov or accessing the NOFO, please contact the Grants.gov Helpdesk at 1-800-518-4726 or via email at [email protected] for technical Assistance. USAID may not award to an applicant unless the applicant has complied with all applicable unique entity identifier and System for Award Management (SAM) requirements detailed in Section D.6.g. The registration process may take many weeks to complete. Therefore, applicants are encouraged to begin registration early in the process. Please send any questions to the point(s) of contact identified in Section G. The deadline for questions is shown above. Responses to questions received prior to the deadline will be furnished to all potential applicants through an amendment to this notice posted to www.grants.gov. Issuance of this notice of funding opportunity does not constitute an award commitment on the part of the Government nor does it commit the Government to pay for any costs incurred in preparation or submission of comments/suggestions or an application. Applications are submitted at the risk of the applicant. All preparation and submission costs are at the applicants expense. Please note that USAID reserves the right to cancel this process at any time without prior notice. Thank you for your interest in USAID programs.` Sincerely,

The "Ending the HIV Epidemic in the U.S. Ryan White HIV/AIDS Program Parts A and B" grant aims to reduce new HIV infections in the U.S. by focusing resources on the most affected areas and implementing strategies for early diagnosis, effective treatment, prevention, and rapid response to outbreaks, while also improving access to care and support services for those diagnosed with HIV.

The John W. Speas & Effie E. Speas Memorial Trust is seeking applications to support and promote quality educational, cultural, human services and health care programming. Donor Name: John W. Speas & Effie E. Speas Memorial Trust State: Kansas, Missouri County: Selected Counties Type of Grant: Grant Deadline: 07/31/2024 Size of the Grant: Not Available Grant Duration: Grant Duration Not Mentioned Details: Program Types Arts, Culture, & Humanities Community Improvement & Capacity Building Education Health Human Services Criteria The Speas Memorial Trust supports organizations that serve the residents of Greater Kansas City Metropolitan area. For more information, visit Bank of America.

This award mechanism focuses on increasing implementation of evidence-based strategies to ensure that all Texans benefit from the cancer prevention knowledge that we currently have. CPRIT seeks to fund multilevel interventions to reduce cancer risk, disease burden, and cancer disparities. Modifiable risk behaviors include tobacco use, obesity, physical inactivity, unhealthy eating, alcohol use, sun exposure, HPV vaccination, Hepatitis B vaccination, and environmental/ occupational cancer exposures. Applications should also assess and address social determinants that contribute to cancer burden and disparities (e.g., cultural factors, unmet needs, access barriers). Interventions and communications should be structured to address the unique circumstances of the population to be served.

The Opioid Abatement Fund Council (OAFC) seeks to combat opioid overdoses in Texas by awarding funds to implement a statewide program that will distribute the opioid overdose reversal medication naloxone where it is needed most, and provide related training, including airway clearance techniques. The Texas Legislature created the OAFC in 2021 to ensure funds collected through lawsuits against pharmaceutical companies are used fairly and efficiently to combat the opioid crisis in Texas. The OAFC is made up of 13 appointed experts and the Texas Comptroller of Public Accounts (CPA) as the non-voting presiding officer.

This is a Notice of Funding Opportunity (NOFO) full package to solicit applications for one cooperative agreement from qualified entities to implement the Integrated Health Systems Strengthening (IHSS). Eligibility for this award is not restricted. The purpose of the Integrated Health System Strengthening (IHSS) program is to accelerate countries Health System Strengthening (HSS) efforts and achieve sustainable, equitable, and resilient health systems through locally-led, evidence-driven, and context-specific approaches to HSS. The primary goals are to advance primary health care (PHC), accelerate progress toward universal health coverage (UHC), and improve health outcomes. Investments in HSS help USAID reach its priority global health goals of preventing child and maternal deaths, controlling the HIV/AIDS epidemic, and combating infectious disease, which directly contributes to strengthening global health security. A strengthened and accessible health system is necessary to yield high-quality health services, which are essential for achieving sustainable improvements in health, promoting economic growth, and overall democratic development.Please find the entire full announcement in the "Related Documents" tab.Issue Date: May 07, 2024Q Due Date: May 21, 2024Closing Date: July 06, 2024Closing Time: 11:59 PM EST (Washington, DC)Amendment 1 with questions/answers has been added: May 31, 2024

The United States Agency for International Development (USAID) is seeking applications for a cooperative agreement from qualified entities to implement the Ftifye Manje pou Ranfse Sante ("Strengthening Food to Boost Health#210;TIFYE). Eligibility for this award is not restricted. USAID intends to make an award to the applicant who best meets the objectives of this funding opportunity based on the merit review criteria described in this NOFO subject to a risk assessment. Eligible parties interested in submitting an application are encouraged to read this NOFO thoroughly to understand the type of program sought, application submission requirements and selection process.To be eligible for award, the applicant must provide all information as required in this NOFO and meet eligibility standards in Section C of this NOFO. This funding opportunity is posted on www.grants.gov, and may be amended. It is the responsibility of the applicant to regularly check the website to ensure they have the latest information pertaining to this notice of funding opportunity and to ensure that the NOFO has been received from the internet in its entirety. USAID bears no responsibility for data errors resulting from transmission or conversion process. If you have difficulty registering on www.grants.gov or accessing the NOFO, please contact the Grants.gov Helpdesk at 1-800-518-4726 or via email at [email protected] for technical assistance.USAID may not award to an applicant unless the applicant has complied with all applicable Unique Entity identifier and System for Award Management (SAM) requirements detailed in Section D.6.g. The registration process may take many weeks to complete. Therefore, applicants are encouraged to begin registration early in the process.Please send any questions to the point(s) of contact identified in Section G. The deadline for questions is shown above. Responses to questions received prior to the deadline will be furnished to all potential applicants through an amendment to this notice posted to www.grants.gov.Issuance of this notice of funding opportunity does not constitute an award commitment on the part of the Government nor does it commit the Government to pay for any costs incurred in preparation or submission of comments/suggestions or an application. Applications are submitted at the risk of the applicants. All preparation and submission costs are at the applicants expense.Thank you for your interest in USAID programs.

This award mechanism seeks to fund projects that will facilitate the dissemination and implementation of successful CPRIT Prevent Program-funded, evidence-based cancer prevention and control interventions across Texas. The proposed project should be able to develop one or more "products" based on the results of a previously CPRIT Prevention Program-funded intervention project. The proposed project should describe and package strategies or approaches for dissemination to other partners, settings, and populations in the state.

The five-year USAID National Family Planning and Adolescent Reproductive Health (FP/ARH) Activity (2024-2029) aims to improve family planning and adolescent reproductive health in the Philippines. It is a key component of the USAID Universal Health Care Project (UHCP) with the goal of improving health outcomes of underserved Filipinos. The FP/ARH Activity will help advance the Philippine governments efforts under the Universal Health Care law to improve the delivery of quality preventive, promotive care at the primary health care level. The Activity will contribute to achieving the Philippine governments health goals as follows: Increase the demand satisfied with modern FP methods among all women of reproductive age from 42 percent in 2022 to 75 percent by 2030; Reduce the adolescent birth rate from 25 per 1,000 girls (age 15-19) in 2022 to 12 per 1,000 girls by 2030; and Reduce the maternal mortality ratio from 144 per 100,000 live births in 2020 to less than 70 per 100,000 live births by 2030